Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : PanAmerican BanCorp (PABN) -- Ignore unavailable to you. Want to Upgrade?

To: jhild who wrote (22175)	1/6/1999 1:29:00 AM
From: Lucky Charm	Read Replies (1) \| Respond to of 43774

Jhild~ Or who ever is on the third shift today... I just wanted to make a comment before I go to bed... I am proud of you, not one big word in your post... Thank You... It makes life for us blondes just sooooooooooo much easier when we don't have look up all those big fancy smancy words... (Duuuuuuuhhhhh) You're doing a great job.... you must have found some sort of 12 step program (I think that's the #, unless you've found more than one program to attend, then of course it would be twelvemo ) for BIG WORDS ANONYMOUS.... CONGRATS Again!!!! Kristi

To: jhild who wrote (22175)	1/6/1999 10:15:00 AM
From: Style Writer	Read Replies (2) \| Respond to of 43774

Here is my response to you and yours: National Health & Safety Corporation Announces Financing forMarketing of Cancer Detection & POWERx Contracts WARMINSTER, Pa., Jan. 6 /PRNewswire/ -- National Health and Safety Corporation (OTC Bulletin Board: NHLT) announced today that it has entered into final stages of negotiations with PanAmerican BanCorp (OTC Bulletin Board: PRWT) of New York to provide up to $6 million in expansion financing. Dr. Dennis Bowers, President and CEO of National Health & Safety Corporation, indicated that the expansion financing will be utilized to service about $125 million in current contracts for its POWERx Medical Benefits Network and for marketing the Longport Soft Tissue Scanner, a device which can detect various forms of cancer without the need for invasive surgical biopsies. National Health & Safety recently announced that it has acquired the exclusive North American marketing rights to the cancer detection technology of Longport. Bowers indicated that NHS projects revenues of about $100 million per year from the Longport technology, which he expects to be submitted to the FDA during the next 90 days. National Health & Safety is currently sponsoring clinical research into the applications of the Longport technology for cancer detection at Thomas Jefferson University Hospital in Philadelphia, PA. Go PRWT